A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRGI gene

A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRGI gene
复制标题

DOI:
10.1002/gcc.10218
复制
发表时间:
2003-08-01
影响因子:
3.7
通讯作者:
Chaffanet, M
Chaffanet, M
中科院分区:
医学2区
文献类型:
--
作者:
Adélaïde, J;Huang, HE;Chaffanet, M

文献摘要

被引文献

相似文献

8p11-21区域是乳腺癌和其他癌症发生改变的常见靶点。我们用多色荧光原位杂交(M-FISH)和bac特异性FISH检测了34个乳腺肿瘤细胞系和9个胰腺癌细胞系的这一区域的变化。我们描述了一个针对8p12上NRG1基因的复发性染色体易位断点。NRG1编码神经调节蛋白/heregulin-1家族的生长因子,这些生长因子是ERBB家族酪氨酸激酶受体的配体。在四种乳腺肿瘤细胞系中发现了NRG1基因的断点:ZR-75-1,在dic中(8;11);HCC1937,在t(8; 10)(p12;p12.1);SUM-52, in an hsr(8)(p12);UACC-812, in a t(3;8);在两种胰腺癌细胞系中:PaTu I,在a (8)t(4;8)中;和SUIT-2,在a del(8)(p)中。双色FISH图谱显示,这些断裂分布在NRG1基因的1.1 Mb范围内。我们已经知道,MDA-MB-175乳腺肿瘤细胞系具有dic(8; 11),在NRG1中有一个断点,将NRG1与11q13上的DOC4基因融合。因此,我们在两种类型的癌细胞系中发现了总共7个断点,这些断点以NRG1基因为靶点。这表明NRG1位点是癌症易位的反复发生的靶点。逆转录细胞系rna的PCR分析揭示了NRG1转录物的广泛复杂性,但未能在具有NRG1断点的细胞系中检测到一致的mRNA亚型模式。(C) 2003 Wiley-Liss, Inc。
The 8p11-21 region is a frequent target of alterations in breast cancer and other carcinomas. We surveyed 34 breast tumor cell lines and 9 pancreatic cancer cell lines for alterations of this region by use of multicolor fluorescence in situ hybridization (M-FISH) and BAC-specific FISH. We describe a recurrent chromosome translocation breakpoint that targets the NRG1 gene on 8p12. NRG1 encodes growth factors of the neuregulin/heregulin-1 family that are ligands for tyrosine kinase receptors of the ERBB family. Breakpoints within the NRG1 gene were found in four of the breast tumor cell lines: ZR-75-1, in a dic(8; 11); HCC1937, in a t(8; 10)(p12;p12.1); SUM-52, in an hsr(8)(p12); UACC-812, in a t(3;8); and in two of the pancreatic cancer cell lines: PaTu I, in a der(8)t(4;8); and SUIT-2, in a del(8)(p). Mapping by two-color FISH showed that the breaks were scattered over 1.1 Mb within the NRG1 gene. It is already known that the MDA-MB-175 breast tumor cell line has a dic(8; 11), with a breakpoint in NRG1 that fuses NRG1 to the DOC4 gene on 11q13. Thus, we have found a total of seven breakpoints, in two types of cancer cell lines, that target the NRG1 gene. This suggests that the NRG1 locus is a recurring target of translocations in carcinomas. PCR analysis of reverse-transcribed cell line RNAs revealed an extensive complexity of the NRG1 transcripts but failed to detect a consistent pattern of mRNA isoforms in the cell lines with NRG1 breakpoint. (C) 2003 Wiley-Liss, Inc.